The role of Chinese medicine in clinical oncology

被引:23
作者
Sun Yan [1 ]
机构
[1] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100210, Peoples R China
关键词
Chinese medicine; clinical oncology; anticancer agents; Fu-zheng therapy; angiogenesis inhibitor; GROWTH;
D O I
10.1007/s11655-013-1551-2
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Chinese Medicine (CM) has been used for several thousand years, playing an important role in the prevention and treatment of diseases including cancer. In the recent four decades, a number of CM herbs have aroused extreme interest in the world-isolating anticancer components from medicinal herbs, using them as biological response modifiers, and most recently as angiogenesis inhibitors. The present review reports both the experimental and clinical results obtained in the field of clinical oncology, especially conducted by our group. The review also presents the possible future of integration of CM and modern medicine in basic research and clinical practice, especially when CM used as adjuvant and maintenance therapy.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 38 条
  • [1] Ahmed B., 2020, OFFICIAL J ZHENDE RE, V1, P1, DOI [10.52152/SPR.2020.100, DOI 10.52152/SPR.2020.100]
  • [2] Chan KL, 1995, IMMUNE MODULATING EF, P651
  • [3] CHU DT, 1988, J CLIN LAB IMMUNOL, V26, P183
  • [4] The Next Wave of Corporate Medicine - How We All Might Benefit
    Cutler, David M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (06) : 549 - 551
  • [5] Two Hundred Years of Cancer Research
    DeVita, Vincent T., Jr.
    Rosenberg, Steven A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (23) : 2207 - 2214
  • [6] Role of angiogenesis in tumor growth and metastasis
    Folkman, J
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (06) : 15 - 18
  • [7] HOU YD, 1981, CHINESE MED J-PEKING, V94, P35
  • [8] Huang Jing-yu, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P1047, DOI 10.3736/jcim20091105
  • [9] Ikezoe T, 2003, INT J ONCOL, V23, P1187
  • [10] Jia JW, 2009, J PRACTICAL ONCOL, V24, P273